The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Abstract
Inflammasomes are Nod-like receptor(NLR)- and caspase-1-containing cytoplasmic multiprotein complexes, which upon their assembly, process and activate the proinflammatory cytokines interleukin (IL)-1beta and IL-18. The inflammasomes harboring the NLR members NALP1, NALP3 and IPAF have been best characterized. While the IPAF inflammasome is activated by bacterial flagellin, activation of the NALP3 inflammasome is triggered not only by several microbial components, but also by a plethora of danger-associated host molecules such as uric acid. How NALP3 senses these chemically unrelated activators is not known. Here, we provide evidence that activation of NALP3, but not of the IPAF inflammasome, is blocked by inhibiting K(+) efflux from cells. Low intracellular K(+) is also a requirement for NALP1 inflammasome activation by lethal toxin of Bacillus anthracis. In vitro, NALP inflammasome assembly and caspase-1 recruitment occurs spontaneously at K(+) concentrations below 90 mM, but is prevented at higher concentrations. Thus, low intracellular K(+) may be the least common trigger of NALP-inflammasome activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In favour of the latter assumption is the recent finding that potassium (K + ) efflux, lowering intracellular K + levels, is a requirement for Nalp3 inflammasome activation triggered by all known activators including MSU (13)(14)(15).”
From Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica (2008) · cites this paper as [13]
In the citing paper
“Recent data also suggest a role for ROS in activating caspase-1 upon ATP treatment (18) and in Nalp3 inflammasome activation by MSU and R837 (13).”
From Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica (2008) · cites this paper as [13]
In the citing paper
“Decreased K+ levels in the cytosolic microenvironment may lead to NLRP3 inflammasome assembly and activation through NIMA-related serine/threonine kinase 7 (Nek7) binding, which culminates in the secretion of inflammatory cytokines, such as IL-1β and IL-18 [151,152]”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [152]
In the citing paper
“Consistently, inhibition of K+ efflux by high extracellular K+ concentrations prevents NLRP3-dependent caspase 1 activation in response to ATP, asbestos, silica and MSU crystals58,66.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [66]
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Self-citationGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Self-citationThe innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., & Aderem, A. A. (2001) · Nature · doi:10.1038/35074106 · Cited by 3,605
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S. L., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,864
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Self-citationBacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3
Kanneganti, T., Özören, N., Body–Malapel, M., Amer, A. O., Park, J., Franchi, L., Whitfield, J. R., Barchet, W., Colonna, M., Vandenabeele, P., et al. (2006) · Nature · doi:10.1038/nature04517 · Cited by 1,149
Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.-D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1346 · Cited by 1,131
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf
Miao, E. A., Alpuche-Aranda, C. M., Dors, M., Clark, A. E., Bader, M. W., Miller, S. I., & Aderem, A. (2006) · Nature Immunology · doi:10.1038/ni1344 · Cited by 1,127
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
Inohara, N., Chamaillard, M., McDonald, C., & Núñez, G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133347 · Cited by 1,019
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,003
Kiyonobu, Y., Ashida, H., Okano, T., Kinoshita-Daitoku, R., Suzuki, S., Ohtani, K., Hamagaki, M., Ikeda, T., & Suzuki, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02406 · Cited by 35
To protect or adversely affect? The dichotomous role of the NLRP1 inflammasome in human disease
Tupik, J. D., Nagai-Singer, M. A., & Allen, I. C. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100858 · Cited by 35
Dual Role of Mitophagy in Cardiovascular Diseases
Li, Y., Meng, W., Hou, Y., Li, D., Wang, X., Wu, K., Sun, S., Liu, H., Li, X., Lin, F., et al. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001046 · Cited by 33
Ren, Y., Feng, J., Lin, Y., Reinach, P. S., Liu, Y., Xia, X., Ma, X., Chen, W., & Zheng, Q. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109096 · Cited by 35
Yu, S., Fu, J., Wang, J., Zhao, Y., Liu, B., Wei, J., Yan, X., & Su, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010135 · Cited by 34
NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases
Wang, J., Chen, S., Liu, M., Zhang, M., & Jia, X. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01026-7 · Cited by 33
Fan, Y., Wu, M., Li, X., Zhao, J., Shi, J., Ding, L., Jiang, H. F., Li, Z., Zhang, W., Ma, T., et al. (2024) · Nutrition Journal · doi:10.1186/s12937-023-00888-z · Cited by 34
Modulation of neuroimmunity by adenosine and its receptors: Metabolism to mental illness
Chiu, G. S., & Freund, G. G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.09.003 · Cited by 37
Eleftheriadis, T., Pissas, G., Karioti, A., Antoniadi, G., Golfinopoulos, S., Liakopoulos, V., Mamara, A., Speletas, M. G., KOUKOULIS, G. N., & Stefanidis, I. (2013) · Europe PMC (PubMed Central) · Cited by 34
York, J. M., Castellanos, K. J., Cabay, R. J., & Fantuzzi, G. (2014) · Translational research · doi:10.1016/j.trsl.2014.06.012 · Cited by 34
The Innate Immune Response Against Staphylococcus aureus
Bekeredjian‐Ding, I., Stein, C., & Uebele, J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5004 · Cited by 38
Marie, C. S., Verkerke, H., Theodorescu, D., & Petri, W. A. (2015) · Scientific Reports · doi:10.1038/srep13613 · Cited by 34
Elevated Systemic Antibodies towards Commensal Gut Microbiota in Autoinflammatory Condition
Manukyan, G. P., Ghazaryan, K. A., Ktsoyan, Z. A., Khachatryan, Z., Arakelova, K. A., Kelly, D., Grant, G., & Aminov, R. I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003172 · Cited by 34
The trigger for pancreatic disease: NLRP3 inflammasome
Liu, T., Wang, Q., Du, Z., Yin, L., Li, J., Meng, X., & Xue, D. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01550-7 · Cited by 33
Regulation and functions of the NLRP3 inflammasome in RNA virus infection
Yue, Z., Zhang, X., Gu, Y., Liu, Y., Lan, L.-M., Liu, Y., Li, Y., Yang, G., Wan, P., & Chen, X. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1309128 · Cited by 35
Zheng, Q., Wang, D., Lin, R., & Xu, W. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00112 · Cited by 34
NLRP3 inflammasome: a novel link between lipoproteins and atherosclerosis
Li, W. L., Hua, L. G., Qu, P., Yan, W. H., Ming, C., Jun, Y. D., Yuan, L. D., & Nan, N. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.61356 · Cited by 33
Esculentoside A exerts anti-inflammatory activity in microglial cells
Yang, H., Chen, Y., Yu, L., & Xu, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.014 · Cited by 34
Tumour viruses and innate immunity
Hopcraft, S. E., & Damania, B. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0267 · Cited by 33
The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury
Huang, S., Che, J., Chu, Q., & Zhang, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00140 · Cited by 33
Understanding the Role of Inflammasomes in Rheumatoid Arthritis
Makkar, R., Behl, T., BUNGAU, S. G., Kumar, A., & Arora, S. (2020) · Inflammation · doi:10.1007/s10753-020-01301-1 · Cited by 35
The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?
Daré, B. L., Ferron, P., & Gicquel, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042139 · Cited by 35
Choudhury, S. M., Ma, X., Zeng, Z., Luo, Z., Li, Y., Nian, X., Ma, Y., Shi, Z., Song, R., Zhu, Z., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02097-21 · Cited by 33
The contribution of ion channels to shaping macrophage behaviour
Selezneva, A. I., Gibb, A. J., & Willis, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.970234 · Cited by 32
Apoptotic Cells Induce NF-κB and Inflammasome Negative Signaling
Grau, A., Tabib, A., Grau, I., Reiner, I., & Mevorach, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122440 · Cited by 34
Zhu, J., Yang, Y. F., Hu, S.-G., Zhang, Q., Yu, J., & Zhang, Y.-M. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4490 · Cited by 33
Chu, F.-X., Wang, X., Li, B., Xu, L., & Di, B. (2024) · Inflammation Research · doi:10.1007/s00011-023-01831-y · Cited by 33
Inflammasome diversity: exploring novel frontiers in the innate immune response
Yu, G., Choi, Y. K., & Lee, S. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.02.004 · Cited by 32
Liu, X., Li, Y., Huang, L., Kuang, Y., Wu, X., Ma, X., Zhao, B., & Lan, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1450704 · Cited by 39
Microparticles and Their Impact on Intestinal Immunity
Becker, H. M., Bertschinger, M. M., & Rogler, G. (2012) · Digestive Diseases · doi:10.1159/000342602 · Cited by 32
Bi̇len, S., Biswas, G., Otsuyama, S., Kono, T., Sakai, M., & Hikima, J.-I. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.04.010 · Cited by 32
Sebum, inflammasomes and the skin: current concepts and future perspective
Oyewole, A. O., & Birch‐Machin, M. A. (2015) · Experimental Dermatology · doi:10.1111/exd.12774 · Cited by 33
Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review
Jamilloux, Y., Bélot, A., Magnotti, F., Benezech, S., Gerfaud‐Valentin, M., Bourdonnay, E., Walzer, T., Sève, P., & Henry, T. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8613-8 · Cited by 33
Kwak, S.-B., Koppula, S., In, E.-J., Sun, X. Y., Kim, Y.-K., Kim, M.-K., Lee, K., & Kang, T. (2018) · Mediators of Inflammation · doi:10.1155/2018/6054069 · Cited by 32
Ma, J.-K., Zhu, S., Guo, Y., Hao, M., Chen, Y., Wang, Y., Yang, M., Chen, J., & Guo, M. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1591-8 · Cited by 32
Kong, D., Kong, F., Liu, X., Yan, C., Cui, J., Tang, R., & Zheng, K. (2019) · Parasites & Vectors · doi:10.1186/s13071-019-3729-8 · Cited by 32
The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers
Gouravani, M., Khalili, N., Razi, S., Keshavarz‐Fathi, M., Khalili, N., & Rezaei, N. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1713755 · Cited by 33
Luo, Y., Xiong, B., Liu, H., Chen, Z., Huang, H., Yu, C., & Yang, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.622074 · Cited by 32
Inflammasome activation and metabolic disease progression
Li, H., Jin, C., Chen, Y., & Flavell, R. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.020 · Cited by 32
Inflammasome Activation by Altered Proteostasis
Shin, J. N., Fattah, E. A., Bhattacharya, A., Ko, S., & Eissa, N. T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.514919 · Cited by 32
Mitochondria–Endoplasmic Reticulum Contact Sites Mediate Innate Immune Responses
Misawa, T., Takahama, M., & Saitoh, T. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_14 · Cited by 32
Eigenbrod, T., Franchi, L., Muñoz-Planillo, R., Kirschning, C. J., Freudenberg, M. A., Núñez, G., & Dalpke, A. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103258 · Cited by 30
The Emerging Role of Inflammasomes as Central Mediators in Inflammatory Bladder Pathology
Inouye, B. M., Hughes, F. M., Sexton, S. J., & Purves, J. T. (2018) · Current Urology · doi:10.1159/000447196 · Cited by 34
Chandrasekharan, A., Varadarajan, S. N., Lekshmi, A., Lupitha, S. S., Darvin, P., Chandrasekhar, L., Pillai, P. R., Santhoshkumar, T. R., & Pillai, M. R. (2018) · Redox Biology · doi:10.1016/j.redox.2018.10.013 · Cited by 30
Tran, U. T., & Kitami, T. (2018) · Communications Biology · doi:10.1038/s42003-018-0244-y · Cited by 31
Purinergic signaling in hepatic disease
Velázquez‐Miranda, E., Díaz‐Muñoz, M., & Vázquez‐Cuevas, F. G. (2019) · Purinergic Signalling · doi:10.1007/s11302-019-09680-3 · Cited by 31
Korhonen, E., Bisevac, J., Hyttinen, J. M. T., Piippo, N., Hytti, M., Kaarniranta, K., Petrovski, G., & Kauppinen, A. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.4.7 · Cited by 31
Activation and Regulation of NLRP3 by Sterile and Infectious Insults
Banerjee, S. K., Chatterjee, A., Gupta, S., & Nagar, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.896353 · Cited by 31
The Significance of NLRP Inflammasome in Neuropsychiatric Disorders
Shen, Y., Qian, L., Luo, H., Li, X., Ruan, Y., Fan, R., Si, Z., Chen, Y.-P., Li, L., & Liu, Y. (2022) · Brain Sciences · doi:10.3390/brainsci12081057 · Cited by 32
Ossola, B., Rifat, A., Rowland, A., Hunter, H., Drinkall, S., Bender, C., Hamlischer, M., Teall, M. R., Burley, R., Barker, D. F., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109330 · Cited by 30
NLRP3 inflammasome as therapeutic targets in inflammatory diseases
Prakash, A. V., Park, I.-H., Park, J. W., Bae, J. P., Lee, G. S., & Kang, T. J. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.099 · Cited by 31
TANGI, T. N., Elmabsout, A. A., Bengtsson, T., Sirsjö, A., & Fransén, K. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1026 · Cited by 31
Human pathogenic fungus Trichophyton schoenleinii activates the NLRP3 inflammasome
Li, H., Wu, S., Mao, L., Lei, G., Zhang, L., Lu, A., An, L., Yang, G., Abliz, P., & Meng, G. (2013) · Protein & Cell · doi:10.1007/s13238-013-2127-9 · Cited by 32
Chen, C., Yang, C.-H., Tsai, Y., Liaw, C., Chang, W.-Y., & Hwang, T. (2016) · Redox Biology · doi:10.1016/j.redox.2016.12.018 · Cited by 33
Takagi, M., Takakubo, Y., Pajarinen, J., Naganuma, Y., Oki, H., Maruyama, M., & Goodman, S. B. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.05.004 · Cited by 31
Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health
Ranson, N., Kunde, D., & Eri, R. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112379 · Cited by 30
García‐Fernández, A., Vivo‐Llorca, G., Sancho, M., García-Jareño, A. B., Ramírez‐Jiménez, L., Barber‐Cano, E., Murguía, J. R., Orzáez, M., Sancenón, F., & Martínez‐Máñez, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071495 · Cited by 31
Auranofin Protects against Anthrax Lethal Toxin-Induced Activation of the Nlrp1b Inflammasome
Newman, Z. L., Sirianni, N., Mawhinney, C., Lee, M. S., Leppla, S. H., Moayeri, M., & Johansen, L. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00772-10 · Cited by 30
Davis, M. J., & Swanson, J. A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310159 · Cited by 30
Basic, A., Alizadehgharib, S., Dahlén, G., & Dahlgren, U. (2017) · Clinical and Experimental Dental Research · doi:10.1002/cre2.69 · Cited by 30
Gomes, M. T. R., Cerqueira, D. M., Guimarães, E. S., Campos, P. C., & Oliveira, S. C. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0119-013r · Cited by 32
Khan, R. A., Afroz, S., Minhas, G., Battu, S., & Khan, N. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154780 · Cited by 30
Inflammasomes in cancer: Effect of epigenetic and autophagic modulations
Mishra, S. R., Mahapatra, K. K., Behera, B. P., Bhol, C. S., Praharaj, P. P., Panigrahi, D. P., Patra, S., Singh, A., Patil, S., Dhiman, R., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.013 · Cited by 31
Demarco, B., Danielli, S., Fischer, F. A., & Bezbradica, J. S. (2022) · Cells · doi:10.3390/cells11081307 · Cited by 30
Role of NLRP3 inflammasome in systemic sclerosis
Lin, C., Jiang, Z., Cao, L., Zou, H., & Zhu, X. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02889-5 · Cited by 33
The double sides of NLRP3 inflammasome activation in sepsis
Vigneron, C., Py, B. F., Monneret, G., & Venet, F. (2023) · Clinical Science · doi:10.1042/cs20220556 · Cited by 34
Targeting inflammasomes in rheumatic diseases
So, A. K.-L., Ives, A., Joosten, L. A. B., & Busso, N. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.61 · Cited by 31
Anantharajah, A., Faure, E., Buyck, J. M., Sundin, C., Lindmark, T., Mecsas, J. C., Yahr, T. L., Tulkens, P. M., Mingeot‐Leclercq, M., Guery, B. P., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw295 · Cited by 30
Ringel-Scaia, V. M., McDaniel, D. K., & Allen, I. C. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2017019158 · Cited by 29
Inflammation—The role of ATP in pre‐eclampsia
Fodor, P., White, B., & Khan, R. N. (2019) · Microcirculation · doi:10.1111/micc.12585 · Cited by 30
Tian, Y., Liu, M., Mao‐Ying, Q., Liu, H., Wang, Z., Zhang, M., Wang, J., Li, Q., Liu, S., Mi, W., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.016 · Cited by 30
Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human
Tewari, M., Michalski, S. A., & Egan, T. M. (2024) · Cells · doi:10.3390/cells13020161 · Cited by 36
Aging as a loss of morphostatic information: A developmental bioelectricity perspective
Pio‐Lopez, L., & Levin, M. G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102310 · Cited by 36
Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome
Cescato, M., Zhu, Y. Y. J., Corre, L. L., Py, B. F., Georgin‐Lavialle, S., & Rodero, M. P. (2024) · Cells · doi:10.3390/cells13161365 · Cited by 32
Ghiasi, S. M., Dahllöf, M. S., Osmai, Y., Osmai, M., Jakobsen, K. K., Aivazidis, A., Tyrberg, B., Perruzza, L., Prause, M. C. B., Christensen, D. P., et al. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.08.001 · Cited by 30
Verma, V., Kumar, P., Gupta, S., Yadav, S., Dhanda, R. S., Thorlacius, H., & Yadav, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-69501-1 · Cited by 30
Zhao, Y., Jiang, S., Zhang, J., Guan, X., Sun, B.-G., & Sun, L. (2021) · Virulence · doi:10.1080/21505594.2021.1926649 · Cited by 30
Ma, S., Zhang, H., & Xu, J. (2021) · Molecules · doi:10.3390/molecules26206205 · Cited by 31
Low potassium disrupt intestinal barrier and result in bacterial translocation
Wu, H., Huang, R., Fan, J., Luo, N., & Yang, X. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03499-0 · Cited by 30
Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection
Islamuddin, M., Mustfa, S. A., Ullah, S. N. M. N., Omer, U., Kato, K., & Parveen, S. (2022) · Inflammation · doi:10.1007/s10753-022-01651-y · Cited by 31
Song, L., Huang, Y., Zhao, M., Wang, Z., Wang, S., Sun, H., Kan, B., Meng, G., Liang, W., & Ren, Z. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00510 · Cited by 29
K⁺ drops tilt the NLRP3 inflammasome.
Kanneganti, T., & Lamkanfi, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.001 · Cited by 25
Yang, H.-H., Jun, H., Jung, Y.-J., & Choi, B. (2014) · Journal of Endodontics · doi:10.1016/j.joen.2014.06.015 · Cited by 29
Kwon, D., Park, E., & Kang, S. (2017) · The FASEB Journal · doi:10.1096/fj.201700328r · Cited by 30
Commensal Microbiota Are Required for Systemic Inflammation Triggered by Necrotic Dendritic Cells
Young, J. A., He, T. H., Reizis, B., & Winoto, A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.033 · Cited by 28
Nod-Like Receptors in Host Defence and Disease at the Epidermal Barrier
Danis, J., & Mellett, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094677 · Cited by 28
ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome
Wu, X., Lv, J.-Y., Zhang, S., Yi, X., Xu, Z., Zhi, Y., Zhao, B., Pang, J., Yung, K. K. L., Liu, S., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00739-9 · Cited by 29
Clostridium perfringens virulence factors are nonredundant activators of the NLRP3 inflammasome
Mathur, A., Kay, C., Xue, Y., Pandey, A., Lee, J., Jing, W., Tuipulotu, D. E., Pilato, J. L., Feng, S., Ngo, C., et al. (2023) · EMBO Reports · doi:10.15252/embr.202254600 · Cited by 30
Seil, M., Ouaaliti, M. E., Fontanils, U., Gorroño, I., Pochet, S., Moro, G. D., Marino, A., & Dehaye, J. (2010) · Purinergic Signalling · doi:10.1007/s11302-010-9205-8 · Cited by 28
P2X7 Receptor as a Key Player in Oxidative Stress-Driven Cell Fate in Nonalcoholic Steatohepatitis
Chatterjee, S., & Das, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/172493 · Cited by 29
Conforti‐Andreoni, C., Beretta, O., Licandro, G., Qian, H. L., Urbano, M., Vitulli, F., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1009652 · Cited by 28
Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease
Shippy, D. C., Evered, A. H., & Ulland, T. K. (2024) · Immunological Reviews · doi:10.1111/imr.13365 · Cited by 33
Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC
Sušjan, P., Lainšček, D., Strmšek, Ž., Hodnik, V., Anderluh, G., & Hafner‐Bratkovič, I. (2020) · The FASEB Journal · doi:10.1096/fj.201902938rr · Cited by 27
Jiang, M., Cui, B., Wu, Y., Zhang, Y., Shang, Y., Liu, J., Yang, H., Qiao, C., Zhan, Z., Ye, H., et al. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.07.023 · Cited by 29
Role of interleukin-1 and inflammasomes in oral disease
Murakami, T., Takahata, Y., Hata, K., & Nishimura, R. (2020) · Journal of Oral Biosciences · doi:10.1016/j.job.2020.07.003 · Cited by 30
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question
Hreich, S. J. D., Benzaquen, J., Hofman, P. M., & Vouret‐Craviari, V. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09811-9 · Cited by 27
Macrophage responses to bacterial toxins: a balance between activation and suppression
Keyel, P. A., Heid, M. E., & Salter, R. D. (2011) · Immunologic Research · doi:10.1007/s12026-011-8212-3 · Cited by 27
MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants
Schuh, E., Groß, C. J., Wagner, D., Schlüter, M., Groß, O., & Kümpfel, T. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.04.004 · Cited by 27
Monitoring gasdermin pore formation in vitro
Xia, S., Ruan, J., & Wu, H. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.04.024 · Cited by 28
Iyer, K., Erkert, L., & Becker, C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1228283 · Cited by 31
Metadata
- Authors
- Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J.
- Affiliations
- University of Lausanne (CH)
- Harvard University (US)
- Corresponding author
- Tschopp, J
- Venue
- Cell Death & Differentiation
- Published
- 2007-06-29
- Volume
- 14
- Issue
- 9
- Pages
- 1583-1589
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1978274182
- Cited by
- 1,445
- References
- 38
- Citations by year
- 2026: 36 · 2025: 54 · 2024: 62 · 2023: 71 · 2022: 85 · 2021: 78 · 2020: 102 · 2019: 86 · 2018: 73 · 2017: 104 · 2016: 70 · 2015: 79 · 2014: 90 · 2013: 101 · 2012: 93
- FWCI
- 25.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- NLRP3 inflammasome, potassium efflux, intracellular potassium concentration, caspase-1 activation, inflammasome assembly, NOD-like receptors, damage-associated molecular patterns, uric acid, IL-1β, IL-18
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Calcium-Binding Proteins, Carrier Proteins, Cell Line, Humans, Inflammation, Mice, Inbred BALB C, Mice, Inbred C57BL, Potassium, Macrophages, Peritoneal, Caspase 1, Interleukin-18, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review